RPS6KA1 and primary cutaneous T-cell non-Hodgkin lymphoma: Altogether, these findings validate a hypothesis of OX-40 signaling promoting ERK-mediated RSK and ELK activation to strengthen tumor-microenvironment interactions and increase metastatic potential in CTCL.